Page last updated: 2024-09-02

schizandrin b and Asthma

schizandrin b has been researched along with Asthma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Chang, JH; Chiang, CY; Chuang, HC; Fan, CK; Hou, TY; Lee, YL; Lin, CL1
Chen, X; Jiang, Y; Jiang, Z; Li, W; Wang, M; Xiao, Z1
Chen, H; Chen, J; Chen, Y; Kong, Y; Li, L; Wang, Q; Xie, H1
Chen, ZC; Cheng, DJ; Guo, YL; Li, XS; Ma, LJ; Tang, XY; Tian, CJ; Zhang, LX; Zhang, XY; Zhao, LM1
Chen, XL; Chen, ZC; Cheng, DJ; Guo, YL; Ma, LJ; Tang, XY; Tian, CJ; Zhang, LX; Zhang, XY; Zhao, LM1

Other Studies

5 other study(ies) available for schizandrin b and Asthma

ArticleYear
Schisandrin B promotes Foxp3
    European journal of pharmacology, 2022, Mar-05, Volume: 918

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Asthma; Cyclooctanes; Dendritic Cells; Disease Models, Animal; Forkhead Transcription Factors; Heme Oxygenase-1; Hypersensitivity; Immunoglobulin E; Immunomodulating Agents; Lignans; Mice; Mice, Inbred BALB C; Polycyclic Compounds; Respiratory Hypersensitivity; T-Lymphocytes, Regulatory; Th2 Cells

2022
Schisandrin B Attenuates Airway Inflammation and Airway Remodeling in Asthma by Inhibiting NLRP3 Inflammasome Activation and Reducing Pyroptosis.
    Inflammation, 2021, Volume: 44, Issue:6

    Topics: Airway Remodeling; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cells, Cultured; Cyclooctanes; Disease Models, Animal; Female; Inflammasomes; Lignans; Lung; Macrophages, Alveolar; MicroRNAs; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Polycyclic Compounds; Pyroptosis; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; TRPC Cation Channels

2021
Schisandrin B Attenuates Airway Inflammation by Regulating the NF-
    Journal of immunology research, 2021, Volume: 2021

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cyclooctanes; Disease Models, Animal; Humans; Lignans; Lung; Male; Mice; NF-E2-Related Factor 2; NF-kappa B; Ovalbumin; Oxidative Stress; Polycyclic Compounds; Signal Transduction; Specific Pathogen-Free Organisms

2021
Schisandrin B down-regulated lncRNA BCYRN1 expression of airway smooth muscle cells by improving miR-150 expression to inhibit the proliferation and migration of ASMC in asthmatic rats.
    Cell proliferation, 2017, Volume: 50, Issue:6

    Topics: Animals; Asthma; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclooctanes; Disease Models, Animal; Down-Regulation; Female; Lignans; MicroRNAs; Myocytes, Smooth Muscle; Polycyclic Compounds; Rats, Sprague-Dawley; RNA, Long Noncoding

2017
Schisandrin B inhibits the proliferation of airway smooth muscle cells via microRNA-135a suppressing the expression of transient receptor potential channel 1.
    Cell biology international, 2016, Volume: 40, Issue:7

    Topics: Airway Remodeling; Animals; Apoptosis; Asthma; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclooctanes; Lignans; Male; MicroRNAs; Myocytes, Smooth Muscle; Polycyclic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; TRPC Cation Channels; Up-Regulation

2016